Treating type 2 diabetes (multiple letters) [3]

British Medical Journal

Volumn 318, Issue 7184, 1999, Pages 666-668

  Narayan, K M V ^a   Beckles, G L A ^a   Gregg, E W ^a   Williamson, D F ^a   Saaddine, J ^a   Engelgau, M M ^a   Vinicor, F ^a   Christiansen, E H ^a   Groetsch, S M ^a   LaVan, J T ^a   Epling, J W ^a   Richards, J ^a   Turner, R ^a   Holman, R ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A;

BLOOD PRESSURE REGULATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LETTER; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL; TREATMENT OUTCOME; VASCULAR DISEASE;

DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; PROSPECTIVE STUDIES;

EID: 0033528435     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)